Page 5 - Mind Cure News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ("Mind Cure" or the "Company"), a leader in developing technology to create psychedelic-related treatments, is pleased to announce the addition of Rob Hill to the Board of Directors. Mr. Hill brings over twenty years of senior leadership experience in capital markets, and specific domain expertise in heavily regulated markets experiencing hyper-growth, big data and compliance management. He has extensive management and board-level experience applying his deep operational and financial knowledge to strategic leaders...

Share this article Share this article Celebrated neurologist, psychiatrist and plant-medicine expert Dr. Dan Engle brings years of understanding of psychedelic medicine into research with Mind Cure. VANCOUVER, BC, Feb. 17, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ( "Mind Cure" or the "Company") is pleased to announce the engagement of Dr. Dan Engle as Mind Cure's Primary Investigator Consultant. Dr. Engle is Board Certified in Psychiatry and Neurology, with a clinical practice that combines functional medicine, integrative psychiatry, neuro-cognitive re...

Rise In Consumer Acceptance of Psychedelic Drug Therapies Is Quickly Increasing Financialnewsmedia.com News Commentary Share this article Share this article PALM BEACH, Fla., Feb. 17, 2021 /PRNewswire/ -- Psychedelics are making their way out of the counterculture and back into the mainstream, with research and media interest in the mind-altering substances growing substantially. Some have even called psychedelics "psychiatry's brave new world." The revitalization of psychedelics has occurred alongside a shift away from the research and development of traditional psychiatric medications by le...

Mind Cure Closes $18M Raise Mind Cure Health Inc. (CSE:MCUR) recently announced the closing of a CA$23 Million ($18.1 million) offering. The company issued approximately 38 million units, consisting of one share and one half of a share purchase warrant, at CA$0.60 per unit.  The proceeds will be used to finance product research and development, advance the company’s technological capabilities, marketing expenditures and product awareness, as well as for working capital. So far, Mind Cure has raised almost CA$31 million ($24.4 million) to date. The company’s operations are divided betwee...

Mind Cure Announces Closing of $23 Million Bought Deal Offering Including Full Exercise of Over-Allotment Option THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Mind Cure Health Inc. a mental health and wellness company with a mission to identify and develop products that ease suffering, increase productivity, and enhance mental health, is pleased to announce that it has closed its previously announced … /THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONL...